This helps explain why this mental health disorder continues to be the leading cause of disability for people between the ages of 15 and 44, according to the Anxiety and Depression Association of ...

Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in the US as a treatment for the rare skin disorder recessive dystrophic ...